Someone asked me this morning about biopharma pricing consultancies, and I ran across the homepage of the firm Precision For Value. They have an interesting homepage aerial map of the product and payer world: From Strategy to Health Outcomes Research to Promotional Effectiveness to Payer Insights to, finally, PayerLand. Homepage
here. Pic below.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjwb2MraSws1N0OKpQMfJfh1c0YSCOoIWWc_-1sOTQmy-FJub1ObJgGd_2xqNOY5_xgobSTjZyLNThPTVzsxVkIJf9eJB-Xa1zsCLf_U8keGsj0dnXysjSEYz5DqBVjhOa4ZG9d1sq3YLg/s400/P4V+Homepage.JPG) |
click to enlarge |
A different consultancy,
Evidera, has a less colorful home page but is currently promoting two interesting white papers. The first is about payer sensitivities to surrogate endpoints (
here), the second is about parallel scientific advice from European payers and life sciences regulators (
here).